Menactra®

Menactra® is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. It is approved for use in individuals 9 months through 55 years of age.
 

1:03:40

Vaccinate against meningococcal meningitis

10 years and still going strong with Menactra
00:03:00

10 years and still going strong with Menactra

0:04:55

IMD Roadshow: Defeating meningitis by 2023: Dr. Jaydeep Choudhury

VIEW ALL

Disclaimer: The images depicted here are fictitious and meant for illustrative purpose only. Any resemblance to any person, living or dead is purely coincidental.